''Shen-Gu granule'' for the prevention and treatment of glucocorticoid-induced osteoporosis.

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031606

Enrollment

Unknown

Registered

2020-04-05

Start date

2020-04-01

Completion date

Unknown

Last updated

2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention and treatment of glucocorticoid-induced osteoporosis

Interventions

Case series:Shen-Gu granule

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with a recent history of GC or a recent plan to take glucocorticoids.

Exclusion criteria

Exclusion criteria: (1) patients with tumor, bone tuberculosis, fracture and other osteoporosis lesions or injuries; (2) pregnant or lactating women; (3) allergic constitution or allergic to the known ingredients of the drug; (4) patients with heart, lung, liver, kidney, hematopoietic system, immune system and other serious diseases.

Design outcomes

Primary

Measure	Time frame
Signs and symptoms related to traditional Chinese medicine;Dual-energy X-ray bone mineral density measurement (DXA);Quality of life:;	—

Countries

China

Contacts

Public ContactOu Yan-Hua

WU HAN JUN AN pharmaceutical Co. Ltd

26075271@qq.com+86 13971067157

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026